Literature DB >> 33362542

SARS-CoV-2 Spike-Heat Shock Protein A5 (GRP78) Recognition may be Related to the Immersed Human Coronaviruses.

Abdo A Elfiky1.   

Abstract

The human coronavirus (HCoV), SARS-CoV-2, caused more than 34 M confirmed infections from which more than 1 M deaths are reported until now (the WHO situation report-154). The current pandemic causes severe socio-economic burden. Due to the importance of understanding of the mode of recognition and viral entry, spike protein shed drug designers as the first look protein target with the first released solved structure on 26 February 2020 (PDB ID: 6VSB). It is proposed that the recognition site for GRP78 is found in SARS-CoV-2 and the immersed human coronaviruses but experimental validation is still required.
Copyright © 2020 Elfiky.

Entities:  

Keywords:  COVID-19; GRP78; HSPA5; SARS-CoV-2; cross-vaccination; host-cell recognition; spike; viral attachment

Year:  2020        PMID： 33362542      PMCID： PMC7759632          DOI： 10.3389/fphar.2020.577467

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN： 1663-9812            Impact factor:   5.810


  14 in total

1.  Targeting heat shock proteins on cancer cells: selection, characterization, and cell-penetrating properties of a peptidic GRP78 ligand.

Authors:  Youngsoo Kim; Antonietta M Lillo; Sebastian C J Steiniger; Ying Liu; Carlo Ballatore; Andrea Anichini; Roberta Mortarini; Gunnar F Kaufmann; Bin Zhou; Brunhilde Felding-Habermann; Kim D Janda
Journal:  Biochemistry       Date:  2006-08-08       Impact factor: 3.162

2.  SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.

Authors:  Julian Braun; Lucie Loyal; Marco Frentsch; Daniel Wendisch; Philipp Georg; Florian Kurth; Stefan Hippenstiel; Manuela Dingeldey; Beate Kruse; Florent Fauchere; Emre Baysal; Maike Mangold; Larissa Henze; Roland Lauster; Marcus A Mall; Kirsten Beyer; Jobst Röhmel; Sebastian Voigt; Jürgen Schmitz; Stefan Miltenyi; Ilja Demuth; Marcel A Müller; Andreas Hocke; Martin Witzenrath; Norbert Suttorp; Florian Kern; Ulf Reimer; Holger Wenschuh; Christian Drosten; Victor M Corman; Claudia Giesecke-Thiel; Leif Erik Sander; Andreas Thiel
Journal:  Nature       Date:  2020-07-29       Impact factor: 49.962

3.  Evidence supporting a zoonotic origin of human coronavirus strain NL63.

Authors:  Jeremy Huynh; Shimena Li; Boyd Yount; Alexander Smith; Leslie Sturges; John C Olsen; Juliet Nagel; Joshua B Johnson; Sudhakar Agnihothram; J Edward Gates; Matthew B Frieman; Ralph S Baric; Eric F Donaldson
Journal:  J Virol       Date:  2012-09-19       Impact factor: 5.103

Review 4.  GRP78: a chaperone with diverse roles beyond the endoplasmic reticulum.

Authors:  Quintin J Quinones; Gustaaf G de Ridder; Salvatore V Pizzo
Journal:  Histol Histopathol       Date:  2008-11       Impact factor: 2.303

5.  Natural products may interfere with SARS-CoV-2 attachment to the host cell.

Authors:  Abdo A Elfiky
Journal:  J Biomol Struct Dyn       Date:  2020-05-05

6.  COVID-19 spike-host cell receptor GRP78 binding site prediction.

Authors:  Ibrahim M Ibrahim; Doaa H Abdelmalek; Mohammed E Elshahat; Abdo A Elfiky
Journal:  J Infect       Date:  2020-03-10       Impact factor: 6.072

7.  Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.

Authors:  Daniel Wrapp; Nianshuang Wang; Kizzmekia S Corbett; Jory A Goldsmith; Ching-Lin Hsieh; Olubukola Abiona; Barney S Graham; Jason S McLellan
Journal:  Science       Date:  2020-02-19       Impact factor: 47.728

Review 8.  Pathogenesis of Middle East respiratory syndrome coronavirus.

Authors:  Judith M A van den Brand; Saskia L Smits; Bart L Haagmans
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

9.  The stress-inducible molecular chaperone GRP78 as potential therapeutic target for coronavirus infection.

Authors:  Dat P Ha; Richard Van Krieken; Anthony J Carlos; Amy S Lee
Journal:  J Infect       Date:  2020-06-12       Impact factor: 6.072

Review 10.  Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids.

Authors:  Amene Saghazadeh; Nima Rezaei
Journal:  Int Immunopharmacol       Date:  2020-05-08       Impact factor: 4.932
View more
  14 in total

1.  Epidemiology and Etiopathogeny of COVID-19.

Authors:  Modesto Leite Rolim Neto; Claúdio Gleidiston Lima da Silva; Maria do Socorro Vieira Dos Santos; Estelita Lima Cândido; Marcos Antônio Pereira de Lima; Sally de França Lacerda Pinheiro; Roberto Flávio Fontenelle Pinheiro Junior; Claudener Souza Teixeira; Sávio Samuel Feitosa Machado; Luiz Fellipe Gonçalves Pinheiro; Grecia Oliveira de Sousa; Lívia Maria Angelo Galvão; Karla Graziely Soares Gomes; Karina Alves Medeiros; Luana Araújo Diniz; Ítalo Goncalves Pita de Oliveira; Jéssica Rayanne Pereira Santana; Maria Aline Barroso Rocha; Irving Araújo Damasceno; Thiago Lima Cordeiro; Wendell da Silva Sales
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Highly conserved s2m element of SARS-CoV-2 dimerizes via a kissing complex and interacts with host miRNA-1307-3p.

Authors:  Joshua A Imperatore; Caylee L Cunningham; Kendy A Pellegrene; Robert G Brinson; John P Marino; Jeffrey D Evanseck; Mihaela Rita Mihailescu
Journal:  Nucleic Acids Res       Date:  2022-01-25       Impact factor: 16.971

3.  Potential antiviral properties of antiplatelet agents against SARS-CoV-2 infection: an in silico perspective.

Authors:  Mohammed A Abosheasha; Afnan H El-Gowily; Abdo A Elfiky
Journal:  J Thromb Thrombolysis       Date:  2021-09-12       Impact factor: 5.221

Review 4.  The effect of SARS-CoV-2 on the nervous system: a review of neurological impacts caused by human coronaviruses.

Authors:  Colin Day; Carson Studders; Kim Arklie; Asees Kaur; Kyra Teetzen; Rebecca Kirsch; Laila Abelseth; Ian Fraser; Emily Abelseth; Stephanie M Willerth
Journal:  Rev Neurosci       Date:  2021-08-13       Impact factor: 4.703

5.  Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts.

Authors:  Zhonglei Wang; Liyan Yang
Journal:  J Ethnopharmacol       Date:  2021-01-21       Impact factor: 5.195

6.  Evaluation and characterization of HSPA5 (GRP78) expression profiles in normal individuals and cancer patients with COVID-19.

Authors:  Jiewen Fu; Chunli Wei; Jiayue He; Lianmei Zhang; Ju Zhou; Kyathegowdanadoddi Srinivasa Balaji; Shiyi Shen; Jiangzhou Peng; Amrish Sharma; Junjiang Fu
Journal:  Int J Biol Sci       Date:  2021-02-18       Impact factor: 6.580

7.  Comparative study of SARS-CoV-2 infection in different cell types: Biophysical-computational approach to the role of potential receptors.

Authors:  Lenin González-Paz; María José Alvarado; María Laura Hurtado-León; Carla Lossada; Joan Vera-Villalobos; Marcos Loroño; J L Paz; Laura N Jeffreys; F Javier Torres; Ysaias J Alvarado
Journal:  Comput Biol Med       Date:  2022-01-20       Impact factor: 4.589

Review 8.  Host cell entry mediators implicated in the cellular tropism of SARS‑CoV‑2, the pathophysiology of COVID‑19 and the identification of microRNAs that can modulate the expression of these mediators (Review).

Authors:  Periklis Katopodis; Emmanouil Karteris; Harpal S Randeva; Demetrios A Spandidos; Sayeh Saravi; Ioannis Kyrou
Journal:  Int J Mol Med       Date:  2021-12-22       Impact factor: 4.101

9.  SARS-CoV-2 variant surge and vaccine breakthrough infection: A computational analysis.

Authors:  Ibrahim Khater; Aaya Nassar
Journal:  Inform Med Unlocked       Date:  2022-02-04

Review 10.  Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19.

Authors:  Byungchang Jin; Rajan Singh; Se Eun Ha; Hannah Zogg; Paul J Park; Seungil Ro
Journal:  World J Gastroenterol       Date:  2021-05-21       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.